retatrutide glp 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

investigated the effects of KRH102053 (2-amino-4-methylsulphanyl-butylic acid-4-methoxy-6-(4-methoxy-benzylamino)-2, 2-dimethyl-chroman-3-yl ester), a novel small-molecule activator of PHD2, in human HOS osteosarcoma, rat PC12 phaeochromocytoma and human HepG2 hepatoma cells

Yoshihisa A, Watanabe S, Yokokawa T, Misaka T, Sato T, Suzuki S, et al

At the same time, GLP-1 receptor activation reduces the activity of pathogenic Th1 and Th17 cells, the effector T cells most directly responsible for autoimmune tissue damage

Universidad de Zaragoza

In this post, well dive into what makes N-Acetyl L-Carnitine HCL so remarkable, its benefits, and why its a cornerstone ingredient in our Brain Support Complex at 2nd Springs